October is Breast Cancer Awareness Month NEW STUDY CONFIRMS EVEN MORE WOMEN WITH BREAST CANCER CAN SKIP CHEMOTHERAPY
18 ott 2021 ·
14 min. 34 sec.
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research expands the number of women with a common type of early stage breast cancer who can skip chemotherapy and safely be treated with hormone-blocking therapies alone – even...
mostra di più
New research expands the number of women with a common type of early stage breast cancer who can skip chemotherapy and safely be treated with hormone-blocking therapies alone – even if their cancer has spread to some of their lymph nodes.[1] However, women whose tumors have spread to their lymph nodes are often at higher risk of worse outcomes, with the majority receiving chemotherapy.[2]
Results from the RxPONDER study, one of the largest clinical trials in hormone receptor-positive, HER2 negative early breast cancer, were presented at the San Antonio Breast Cancer Symposium in late 2020.1
Based on these new findings, postmenopausal women whose cancer has spread to between one and three lymph nodes can avoid the side effects associated with chemotherapy if their Oncotype DX Breast Recurrence Score® result, a genomic test which predicts chemotherapy benefit and risk of cancer recurrence, is between...
for video and more info go to https://goodnewsplanet.com/october-is-breast-cancer-awareness-month-new-study-confirms-even-more-women-with-breast-cancer-can-skip-chemotherapy/
##breast #cancer #chemotherapy #therapies #hormone #blocking #lymph #nodes #rxponder #menopausal #effects #oncotype #dx #recurrence #genomic #benefit #risk #exact
mostra meno
Results from the RxPONDER study, one of the largest clinical trials in hormone receptor-positive, HER2 negative early breast cancer, were presented at the San Antonio Breast Cancer Symposium in late 2020.1
Based on these new findings, postmenopausal women whose cancer has spread to between one and three lymph nodes can avoid the side effects associated with chemotherapy if their Oncotype DX Breast Recurrence Score® result, a genomic test which predicts chemotherapy benefit and risk of cancer recurrence, is between...
for video and more info go to https://goodnewsplanet.com/october-is-breast-cancer-awareness-month-new-study-confirms-even-more-women-with-breast-cancer-can-skip-chemotherapy/
##breast #cancer #chemotherapy #therapies #hormone #blocking #lymph #nodes #rxponder #menopausal #effects #oncotype #dx #recurrence #genomic #benefit #risk #exact
Informazioni
| Autore | Paul Sladkus |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
